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Large-scale clinical studies have established that hyperglycemia, the defining metabolic abnormality in dia-EFFECTS OF GLYCATED PROTEINS IN betes mellitus, increases the risk for diabetic renal dis-THE KIDNEY ease [1, 2] . Although these studies did not define the Earlier work demonstrated that glycated proteins inresponsible mechanisms, research in the past decade has fluence renal function and have distinct renal handling. shown that hyperglycemia has deleterious effects on kidInfusion of Amadori-modified plasma proteins into norney cell function. Renal cell lines grown in high glucose mal rats induces glomerular hyperfiltration [6] , an early media exhibit activation of intracellular signaling pathfunctional feature of diabetes, and repeated injections of ways [3] , up-regulation of the transforming growth facglycosylated proteins into normal mice produce "pseudotor-␤ (TGF-␤) system [4] , and a consequent overproducdiabetic" renal glomerular changes [7] . Glycated proteins tion of extracellular matrix molecules [5] that leads to alter the permeability properties of the glomerular capilglomerulosclerosis, tubulointerstitial fibrosis, and renal lary wall [8] and are preferentially transported across the glomerular filtration barrier and into the mesangial space [9] . They appear in the urinary space in greater amounts as evidenced by their increased clearance rates from the bloodstream, but final glycated protein concen-
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trations in urine actually decrease relative to those of of a PKC-specific substrate, and in the PKC-␤1 isoform activity, measured by the degree of cytosol-to-membrane nonglycated proteins as patients with diabetes progress from normoalbuminuria to frank proteinuria [10] . This translocation of this isoform [20] . We have performed experiments of similar design with rat glomerular endosuggests preferential tubule cell uptake of the glycated forms of protein, which may have adverse consequences thelial cells and shown that glycated albumin also stimulates PKC activity in this cell type independently of high in the tubulointerstitial compartment and in the renal microvasculature. Endothelial cells preferentially take glucose concentrations [21] . up circulating glycated proteins, which may lead to endoGlycated proteins activate the TGF-␤ system thelial dysfunction and contribute to diabetic microangiopathy [11] .
TGF-␤, a hypertrophic and prosclerotic cytokine, plays a pivotal role in mediating the morphologic changes Glycated protein receptors characteristic of diabetic nephropathy [22] . The biologic effects of TGF-␤ in kidney cells, which include cell hyperPutative mesangial and endothelial cell receptors recognize the Amadori-glycated form of albumin [12] . Litrophy and stimulation of extracellular matrix production, closely resemble those of hyperglycemia [23] . We gand binding studies conducted on phenotypically stable, nontransformed mesangial cells have demonstrated sehave reported that proximal tubule epithelial cells, mesangial cells, and renal interstitial cells and fibroblasts lective binding of glycated albumin in a dose-dependent and saturable manner and are consistent with the exiscultured in high ambient glucose express significantly increased TGF-␤1 mRNA levels and bioactivity [24] [25] [26] [27] . tence of more than one affinity class of glycated albumin receptors [12] . In competition experiments, a mono-
The TGF-␤ system in turn stimulates collagen synthesis in these cells [4, 27] . To examine whether glycated albuclonal antiglycated albumin antibody specifically inhibits binding of glycated albumin to the mesangial cell recepmin, independent of high ambient glucose, modulates the TGF-␤ system in renal cells, we exposed cultured tor, without interfering with binding of nonglycated albumin to mesangial cells [12] . Although further work needs mouse mesangial cells to normal glucose media containing glycated albumin at concentrations found in clinical specto be done to characterize the receptors for glycated albumin, it is reasonable to surmise that activation of imens [28] . Northern blot analysis revealed that glycated albumin significantly stimulated TGF-␤1 mRNA levels this receptor by ligand binding may transduce important downstream pathobiologic effects.
by approximately twofold compared with nonglycated albumin. It also induced a concomitant twofold increase Glycated albumin increases protein kinase C activity in the mRNA expression of the type II TGF-␤ receptor, the primary signaling receptor for TGF-␤. Extrapolated Several studies have shown that the protein kinase C (PKC) system is up-regulated in the diabetic state. PKC to the in vivo situation, these results suggest that glycated albumin, which has a circulating half-life of about 2 activity, measured by the cytosol-to-membrane shift of various classical PKC isoforms, is increased in mesangial weeks, may continue to influence the TGF-␤ system long after restoration of normoglycemia. Further, glycated and endothelial cells incubated in high glucose media [13] [14] [15] [16] . Glomeruli from diabetic rodents also display albumin was nearly as potent as high glucose in stimulating expression of both TGF-␤1 and its receptor. Addielevated PKC activity and cytosol-to-membrane translocation of diacylglycerol-sensitive PKC isoforms [17, 18] .
tionally, glycated albumin in high glucose media caused an even greater increase in the TGF-␤1 and type II TGF-␤ Based on a series of 14 C-radiolabeling experiments, the relationship between hyperglycemia and PKC activation receptor mRNAs [28] . Thus by stimulating the TGF-␤ system at both the ligand and receptor levels, glycated has been ascribed to an increased intracellular metabolism of glucose that promotes de novo formation of diacylalbumin can amplify the pathobiologic effects of TGF-␤ and can conspire with hyperglycemia to sustain these glycerol, the major endogenous activator of PKC [19] . Our work has suggested additional mechanisms. Notaeffects. bly, Amadori-glycated albumin, independent of glucose, Glycated proteins stimulate extracellular can trigger PKC activation in glomerular cells [20] .
matrix synthesis We assayed PKC activity in two renal cell types after incubation with concentrations of glycated albumin that Mesangial expansion due to overproduction of extracellular matrix proteins causes gradual obliteration of are found in diabetic subjects. Cells incubated with equal concentrations of nonglycated albumin served as the glomerular capillary lumens and a progressive decline in effective filtration surface area [29] . Given the central controls, and experiments were performed in normal glucose media to avoid the confounding effects of high importance of the mesangium in diabetic nephropathy, we first examined the responses of mesangial cells to glucose on the PKC system. Both rat and mouse mesangial cells exhibited significant increases in the overall glycated proteins [30] . The primary endpoint in these studies was expression of type IV collagen, the predomi-PKC activity, measured by the extent of phosphorylation
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nant constituent of the expanded mesangial matrix in in mesangial cells, generalized PKC inhibition by GF 109203X prevents the increased type IV collagen producdiabetes. Mouse mesangial cells incubated for 72 h in tion [21] . media containing glycated serum proteins and a normal
The TGF-␤ system also mediates the glycated proteinglucose concentration displayed increased ␣1(IV) collainduced increases in extracellular matrix production [28] . gen mRNA, an effect that was exaggerated in high glu-
The increase in fibronectin expression by mesangial cells cose media [31] . Inclusion of a monoclonal antibody incubated with glycated serum or glycated albumin is (A717), site-specific for Amadori glucose adducts in glyprevented when the cells are concurrently treated with cated albumin, prevented the increase in type IV collaa neutralizing anti-TGF-␤ antibody [28] . Similarly, the gen production, indicating that glycated albumin was elevation in type IV collagen production by glomerular primarily responsible for the observed effect due to glyendothelial cells incubated with glycated albumin is atcated serum proteins. Subsequent experiments established tenuated in the presence of neutralizing anti-TGF-␤ antithat glycated serum and glycated albumin significantly bodies [21] . Further, inhibition of PKC with GF 109203X increased the expression of another matrix protein, fiprevents stimulation of both TGF-␤ and type IV collagen bronectin, and that this effect was also accentuated in proteins, suggesting that PKC may indirectly signal inhigh glucose media [28] . creased extracellular matrix production by stimulating In keeping with the paradigm that glycated albumin the TGF-␤ system [36] . The presence of several PKCcontributes substantially to structural and functional abresponsive activated protein (AP-1) binding sites on the normalities associated with diabetic renal disease, we promoter of the TGF-␤1 gene supports this hypothesis more recently studied the effects of this glycated protein [37, 38] . on the production of matrix by glomerular endothelial cells [21, 32] . Compared with nonglycated albumin, glyGlycated proteins in animal models of cated albumin significantly increased the expression of diabetic nephropathy fibronectin and type IV collagen, effects that were preAnimal studies have confirmed that the in vitro effects vented by the A717 antiglycated albumin monoclonal of glycated proteins are relevant in vivo, and that they antibody. Thus, the glomerular endothelium, strategiplay an important role in the pathophysiology of diabetic cally positioned between the circulation and the other renal disease. The db/db mouse represents an animal glomerular elements, responds to an elevated glycated model of type 2 diabetes that develops glomerulopathy protein concentration in ways that promote glomerular closely resembling that found in the human disease pathology.
[39, 40] . As in humans, glycated albumin levels are two-to Glomerular epithelial cells also respond to glycated threefold higher in diabetics than in nondiabetic controls. proteins with increased extracellular matrix synthesis.
Chronic administration of Fab fragments of the monoCells exposed to glycated fetal bovine serum (FBS) comspecific antiglycated albumin antibody, A717, signifipared with those exposed to nonglycated FBS show incantly lowers the plasma glycated albumin concentration creased laminin protein and basement membrane matrix, in the db/db mouse [41] . After 8 weeks of treatment, the but unchanged type I collagen and fibronectin proteins A717-treated db/db mice had significantly less urinary [33] . Glycated FBS also decreases collagenase activity, albumin excretion than the db/db mice treated with irrelsuggesting that in glomerular epithelial cells, glycated evant IgG, nearly achieving the normoalbuminuric state proteins promote extracellular matrix accumulation in of the nondiabetic db/m controls [41] . The antibody part through inhibition of matrix degradation. treatment protocol also remarkably improved glomerular pathology. Glomeruli from IgG-treated db/db conMediators of glycated protein-induced trols showed diffuse mesangial expansion that encroached extracellular matrix on the normal capillary network, whereas the glomeruli Activation of the PKC signaling pathway by glycated from A717-treated db/db mice showed considerably less proteins has been causally linked to increased extracellumesangial expansion. Northern blot analysis revealed lar matrix expression [20] . Incubation with glycated albuthat the gene expression of both ␣1(IV) collagen and min activates PKC in cultured rat and mouse mesangial fibronectin were significantly increased in db/db mice comcells, and when overall PKC activity is blocked by GF pared with that in db/m mice [41] . Additional experi-109203X, the glycated albumin-evoked increase in type ments demonstrated that the lowering of plasma glycated IV collagen production is prevented. Likewise, when albumin in db/db mice by A717 delayed the development PKC-␤ activity is specifically blocked by LY-379196, the of renal insufficiency, assessed by the level of azotemia increase in type IV collagen synthesis is prevented to and the creatinine clearance [42] . the same degree, consistent with the notion that the ␤ Glycated proteins in human diabetic nephropathy isoform plays a predominant role among the PKC isotypes [34, 35] . Glomerular endothelial cells also respond Few human studies have examined the role of Amadori-glycated proteins in the progression of diabetic reto glycated albumin with increased PKC activity. As
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ciency in diabetic mice. The mechanisms by which glycated serum proteins induce pathobiologic events in the renal glomerulus are incompletely defined but may relate to receptor-induced events followed by PKC-mediated TGF-␤ activation (Fig. 1) . Given that increased glycated albumin levels potently stimulate renal extracellular matrix production, therapeutic strategies that negate the effects of glycated albumin are a logical approach to the treatment of diabetic nephropathy. who had nephropathy had significantly higher levels of gial matrix expansion, proteinuria, and renal insuffi-
